Cargando…

Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast Cancer

SIMPLE SUMMARY: Circulating tumor cells are precursors of distant metastasis in many cancer types. These cells circulate in the peripheral blood, which can be analyzed in a non-invasive procedure to identify patients at risk to develop metastases. In order to improve non-invasive diagnostic procedur...

Descripción completa

Detalles Bibliográficos
Autores principales: Welsch, Eva, Schuster, Eva, Krainer, Michael, Marhold, Maximilian, Bartsch, Rupert, Fischer, Michael B., Hermann, Michael, Hastermann, Gabriele, Uher, Heidemarie, Sliutz, Gerhard, Anker, Birgit, Zeillinger, Robert, Obermayr, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954525/
https://www.ncbi.nlm.nih.gov/pubmed/36831613
http://dx.doi.org/10.3390/cancers15041271
_version_ 1784894138792017920
author Welsch, Eva
Schuster, Eva
Krainer, Michael
Marhold, Maximilian
Bartsch, Rupert
Fischer, Michael B.
Hermann, Michael
Hastermann, Gabriele
Uher, Heidemarie
Sliutz, Gerhard
Anker, Birgit
Zeillinger, Robert
Obermayr, Eva
author_facet Welsch, Eva
Schuster, Eva
Krainer, Michael
Marhold, Maximilian
Bartsch, Rupert
Fischer, Michael B.
Hermann, Michael
Hastermann, Gabriele
Uher, Heidemarie
Sliutz, Gerhard
Anker, Birgit
Zeillinger, Robert
Obermayr, Eva
author_sort Welsch, Eva
collection PubMed
description SIMPLE SUMMARY: Circulating tumor cells are precursors of distant metastasis in many cancer types. These cells circulate in the peripheral blood, which can be analyzed in a non-invasive procedure to identify patients at risk to develop metastases. In order to improve non-invasive diagnostic procedures for breast cancer, we aimed at investigating gene transcripts as liquid biopsy markers in the blood employing density gradient centrifugation as a cost- and time-saving method for the isolation of the target cells. We were able to detect the selected biomarkers in 86.1% of metastatic and 31.1% of early breast cancer patients. The presence of some markers were significantly related with shorter survival of the patients. Our data suggest that these transcripts have the potential to identify patients with poor prognosis who might benefit from further clinical intervention. ABSTRACT: Liquid biopsy is a promising tool for therapy monitoring of cancer patients, but a need for further research in this field exists in order to improve sensitivity, specificity, standardization and minimize costs. In our present study, we evaluated two panels of transcripts related with the presence of circulating tumor cells (CTCs) (Panel 1: CK19, EpCAM, SCGB2A2 and Panel 2: EMP2, SLC6A8, HJURP, MAL2, PPIC and CCNE2) in two cohorts of breast cancer patients (metastatic and early). A blood cell fraction possibly containing CTCs was isolated with density gradient centrifugation, followed by RNA isolation and qPCR using TaqMan(®) or RT-qPCR using hybridization probes. The positivity rates of the investigated panels were similar, albeit higher in metastatic (69.4% Panel 1, 75.0% Panel 2; total 86.1%) compared to early (18.9% Panel 1, 23.3% Panel 2; total 31.1%) breast cancer patients. CK19, SCGB2A2, EMP2, HJURP, MAL2, and CCNE2 individually correlated with shorter overall survival in the metastatic patient cohort. The findings highlight the additional value of Panel 2 markers, which are in contrast to CK19 and EpCAM not solely linked to an epithelial phenotype.
format Online
Article
Text
id pubmed-9954525
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99545252023-02-25 Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast Cancer Welsch, Eva Schuster, Eva Krainer, Michael Marhold, Maximilian Bartsch, Rupert Fischer, Michael B. Hermann, Michael Hastermann, Gabriele Uher, Heidemarie Sliutz, Gerhard Anker, Birgit Zeillinger, Robert Obermayr, Eva Cancers (Basel) Article SIMPLE SUMMARY: Circulating tumor cells are precursors of distant metastasis in many cancer types. These cells circulate in the peripheral blood, which can be analyzed in a non-invasive procedure to identify patients at risk to develop metastases. In order to improve non-invasive diagnostic procedures for breast cancer, we aimed at investigating gene transcripts as liquid biopsy markers in the blood employing density gradient centrifugation as a cost- and time-saving method for the isolation of the target cells. We were able to detect the selected biomarkers in 86.1% of metastatic and 31.1% of early breast cancer patients. The presence of some markers were significantly related with shorter survival of the patients. Our data suggest that these transcripts have the potential to identify patients with poor prognosis who might benefit from further clinical intervention. ABSTRACT: Liquid biopsy is a promising tool for therapy monitoring of cancer patients, but a need for further research in this field exists in order to improve sensitivity, specificity, standardization and minimize costs. In our present study, we evaluated two panels of transcripts related with the presence of circulating tumor cells (CTCs) (Panel 1: CK19, EpCAM, SCGB2A2 and Panel 2: EMP2, SLC6A8, HJURP, MAL2, PPIC and CCNE2) in two cohorts of breast cancer patients (metastatic and early). A blood cell fraction possibly containing CTCs was isolated with density gradient centrifugation, followed by RNA isolation and qPCR using TaqMan(®) or RT-qPCR using hybridization probes. The positivity rates of the investigated panels were similar, albeit higher in metastatic (69.4% Panel 1, 75.0% Panel 2; total 86.1%) compared to early (18.9% Panel 1, 23.3% Panel 2; total 31.1%) breast cancer patients. CK19, SCGB2A2, EMP2, HJURP, MAL2, and CCNE2 individually correlated with shorter overall survival in the metastatic patient cohort. The findings highlight the additional value of Panel 2 markers, which are in contrast to CK19 and EpCAM not solely linked to an epithelial phenotype. MDPI 2023-02-16 /pmc/articles/PMC9954525/ /pubmed/36831613 http://dx.doi.org/10.3390/cancers15041271 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Welsch, Eva
Schuster, Eva
Krainer, Michael
Marhold, Maximilian
Bartsch, Rupert
Fischer, Michael B.
Hermann, Michael
Hastermann, Gabriele
Uher, Heidemarie
Sliutz, Gerhard
Anker, Birgit
Zeillinger, Robert
Obermayr, Eva
Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast Cancer
title Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast Cancer
title_full Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast Cancer
title_fullStr Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast Cancer
title_full_unstemmed Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast Cancer
title_short Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast Cancer
title_sort comparison of rna marker panels for circulating tumor cells and evaluation of their prognostic relevance in breast cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954525/
https://www.ncbi.nlm.nih.gov/pubmed/36831613
http://dx.doi.org/10.3390/cancers15041271
work_keys_str_mv AT welscheva comparisonofrnamarkerpanelsforcirculatingtumorcellsandevaluationoftheirprognosticrelevanceinbreastcancer
AT schustereva comparisonofrnamarkerpanelsforcirculatingtumorcellsandevaluationoftheirprognosticrelevanceinbreastcancer
AT krainermichael comparisonofrnamarkerpanelsforcirculatingtumorcellsandevaluationoftheirprognosticrelevanceinbreastcancer
AT marholdmaximilian comparisonofrnamarkerpanelsforcirculatingtumorcellsandevaluationoftheirprognosticrelevanceinbreastcancer
AT bartschrupert comparisonofrnamarkerpanelsforcirculatingtumorcellsandevaluationoftheirprognosticrelevanceinbreastcancer
AT fischermichaelb comparisonofrnamarkerpanelsforcirculatingtumorcellsandevaluationoftheirprognosticrelevanceinbreastcancer
AT hermannmichael comparisonofrnamarkerpanelsforcirculatingtumorcellsandevaluationoftheirprognosticrelevanceinbreastcancer
AT hastermanngabriele comparisonofrnamarkerpanelsforcirculatingtumorcellsandevaluationoftheirprognosticrelevanceinbreastcancer
AT uherheidemarie comparisonofrnamarkerpanelsforcirculatingtumorcellsandevaluationoftheirprognosticrelevanceinbreastcancer
AT sliutzgerhard comparisonofrnamarkerpanelsforcirculatingtumorcellsandevaluationoftheirprognosticrelevanceinbreastcancer
AT ankerbirgit comparisonofrnamarkerpanelsforcirculatingtumorcellsandevaluationoftheirprognosticrelevanceinbreastcancer
AT zeillingerrobert comparisonofrnamarkerpanelsforcirculatingtumorcellsandevaluationoftheirprognosticrelevanceinbreastcancer
AT obermayreva comparisonofrnamarkerpanelsforcirculatingtumorcellsandevaluationoftheirprognosticrelevanceinbreastcancer